5L
PFE icon

55I LLC’s Pfizer PFE Stock Holding History

55I LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.91M Buy
66,404
+42,033
+172% +$2.04M 0.08% 146
2022
Q2 		$1.28M Buy
24,371
+3,342
+16% +$170K 0.04% 226
2022
Q1 		$1.09M Buy
21,029
+5,590
+36% +$290K 0.03% 250
2021
Q4 		$913K Buy
15,439
+2,255
+17% +$112K 0.02% 252
2021
Q3 		$567K Buy
13,184
+2,990
+29% +$132K 0.02% 305
2021
Q2 		$399K Buy
10,194
+4,171
+69% +$162K 0.01% 290
2021
Q1 		$218K Buy
+6,023
New +$214K 0.01% 287
2020
Q4 		– Sell
-6,306
Closed -$220K – 283
2020
Q3 		$220K Buy
+6,306
New +$221K 0.02% 254

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

55I LLC's PFE Position: Q3 2022 in Review

55I LLC increased its Pfizer (PFE) stake by 172% in Q3 2022, buying an estimated $2.04M and bringing the position to 66,404 shares worth $2.91M. The position accounts for 0.08% of the portfolio, ranked #146.

55I LLC first reported a position in PFE in Q3 2020 and has held it in 8 quarters since. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • 55I LLC held 66,404 shares of Pfizer worth $2.91M as of Q3 2022.
  • 55I LLC bought 42,033 Pfizer shares in Q3 2022, an estimated $2.04M.
  • Pfizer made up 0.08% of 55I LLC's portfolio in Q3 2022, its #146 holding.
  • 55I LLC first reported a position in Pfizer in Q3 2020 and has held it in 8 quarters since.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.